GOSS Archives - Page 4 of 7

1 minute read

Analyst Downgrades Gossamer Bio As Merck’s Sotatercept Might Overshadow Seralutinib’s Success

March 7, 2:37 PM

Raymond James has downgraded Gossamer Bio Inc (NASDAQ:GOSS) to Market Perform from Outperform following the publication of sotatercept’s Phase 3 data in NEJM. …

GOSS

2 minute read

Looking Into Gossamer Bio’s Recent Short Interest

By Benzinga Insights

January 3, 12:36 PM

Gossamer Bio's (NASDAQ:GOSS) short percent of float has fallen 32.89% since its last report. The company recently reported that it has 14.41 million shares sold short, which is 17.59% of all regular shares that are available for trading.

GOSS

9 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

December 23, 1:16 PM

OnFriday, 143 stocks hit new 52-week lows.

ACHR

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

December 22, 1:32 PM

Gainers IsoPlexis (NASDAQ:ISO) stock moved upwards by 131.1% to $1.59 during Thursday’s regular session. Trading volume for IsoPlexis’s…

ALVO

5 minute read

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

December 19, 2:38 PM

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

ACLX

2 minute read

Lowe’s To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday

By Lisa Levin

December 8, 9:04 AM

Goldman Sachs raised Lowe’s Companies, Inc. (NYSE:LOW) price target from $241 to $246. . Goldman Sachs analyst Kate…

CPB

1 minute read

HC Wainwright & Co. Maintains Buy on Gossamer Bio, Lowers Price Target to $5

By Benzinga Newsdesk

December 8, 7:24 AM

HC Wainwright & Co. analyst Patrick Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $25 to $5.

GOSS

4 minute read

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

December 7, 2:45 PM

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.

ALVO

1 minute read

Goldman Sachs Maintains Buy on Gossamer Bio, Lowers Price Target to $10

By Benzinga Newsdesk

December 7, 9:50 AM

Goldman Sachs analyst Paul Choi maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $22 to $10.

GOSS

2 minute read

ConocoPhillips To Rally Over 30%? Here Are 10 Other Price Target Changes For Wednesday

By Lisa Levin

December 7, 8:46 AM

Barclays raised ConocoPhillips (NYSE: COP) price target from $135 to $151. Barclays analyst Jeanine Wai maintained an Overweight rating on the stock. ConocoPhillips shares fell 3.2% to close at $115.61 on Tuesday.

ABNB

Feed Symbols: GOSS